Journal Information
Why Publish in Blood Cancer Journal?
- Publishes high quality articles about hematologic malignancies and related disorders.
- World's leading voices form the expert editorial team, that offers rapid turnaround times.
- Open access publication ensures that your work is easily discovered, accessed, and shared.
Aims and scope of journal
Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field.
Topics of particular interest include, but are not limited to, the following:
- Preclinical studies of new compounds, especially those that provide mechanistic insights
- Clinical trials and observations
- Reviews related to new drugs and current management of hematologic malignancies
- Novel observations related to new mutations, molecular pathways, and tumor genomics
Blood Cancer Journal offers a forum for expedited publication of novel observations regarding new mutations or altered pathways.
Journal Metrics
Article metrics such as number of downloads, citations and online attention are available from each article page, and provide an overview of the attention received by a paper.
Citation Impact 2023
- Journal Impact Factor: 12.9
- 5-year Journal Impact Factor: 11.0
- Source Normalized Impact per Paper (SNIP): 2.487
- SCImago Journal Rank (SJR): 3.974
Speed 2023
- Submission to first editorial decision (median days): 6
- Submission to acceptance (median days): 82
Usage 2023
- Downloads: 1,528,972
- Altmetric mentions: 3,296
Abstracted/indexed in
Biological Abstracts
Biosis Previews
DOAJ
Google Scholar
ISI Web of Science
PubMed/MEDLINE
Scopus
ISSN
The ISSN (online) number for Blood Cancer Journal is 2044-5385.
